Valeo Pharma Inc. (VPHIF)
VPHIF Stock Price Chart
Explore Valeo Pharma Inc. interactive price chart. Choose custom timeframes to analyze VPHIF price movements and trends.
VPHIF Company Profile
Discover essential business fundamentals and corporate details for Valeo Pharma Inc. (VPHIF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
23 Sept 2020
Employees
70.00
Website
https://www.valeopharma.comCEO
Al Moghaddam B. Cma
Description
Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceutical products with primary focus on respiratory, speciality, and hospital generic products in Canada. Its product portfolio includes Enerzair Breezhaler, an LABA/LAMA/ICS fixed triple dose asthma drug; Atectura Breezhaler, an LABA/ICS dual combination asthma drug; Redesca, to treat and prevent deep vein thrombosis and pulmonary embolism; Onstryv, Idiopathic Parkinson's Disease (PD) as an add-on for patients on stable dose of Levodopa alone or in combination with other drugs; M-Eslon, extended-release morphine sulphate used for pain management; and Yondelis, a soft tissue sarcoma. In addition, it offers Hesperco, bioflavonoid antioxidant used for immune support; Ametop, for skin Anesthesia prior to venepuncture or venous cannulation; Benztropine, an VPI-Anticholinergic agent used for the treatment of PD; Ethacrynate Sodium, a loop diuretic for high blood pressure and associated swelling; and Amikacin, an injectable antibiotic. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.
VPHIF Financial Timeline
Browse a chronological timeline of Valeo Pharma Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Sept 2025
Earnings released on 11 Jun 2025
Earnings released on 31 Jan 2025
Earnings released on 12 Sept 2024
EPS came in at -$0.06 falling short of the estimated -$0.04 by -65.23%, while revenue for the quarter reached $9.08M , missing expectations by -7.12%.
Earnings released on 13 Jun 2024
EPS came in at -$0.06 falling short of the estimated -$0.04 by -59.55%, while revenue for the quarter reached $10.33M , missing expectations by -8.14%.
Earnings released on 15 Mar 2024
EPS came in at -$0.06 falling short of the estimated -$0.06 by -6.40%, while revenue for the quarter reached $10.07M , missing expectations by -5.96%.
Earnings released on 31 Oct 2023
EPS came in at -$0.07 , while revenue for the quarter reached $9.52M .
Earnings released on 14 Sept 2023
EPS came in at -$0.05 falling short of the estimated -$0.04 by -20.54%, while revenue for the quarter reached $10.55M , missing expectations by -15.15%.
Earnings released on 14 Jun 2023
EPS came in at -$0.06 falling short of the estimated -$0.05 by -10.13%, while revenue for the quarter reached $9.97M , missing expectations by -2.92%.
Earnings released on 30 Jan 2023
EPS came in at -$0.13 falling short of the estimated -$0.05 by -160.00%, while revenue for the quarter reached $9.86M , beating expectations by +0.10%.
Earnings released on 31 Oct 2022
EPS came in at -$0.09 , while revenue for the quarter reached $9.28M .
Earnings released on 13 Sept 2022
EPS came in at -$0.06 falling short of the estimated -$0.05 by -20.00%, while revenue for the quarter reached $4.73M , beating expectations by +0.98%.
Earnings released on 14 Jun 2022
EPS came in at -$0.06 matching the estimated -$0.06, while revenue for the quarter reached $3.71M , missing expectations by -26.34%.
Earnings released on 24 Mar 2022
EPS came in at -$0.07 falling short of the estimated -$0.04 by -100.00%, while revenue for the quarter reached $3.34M , missing expectations by -17.98%.
Earnings released on 31 Oct 2021
EPS came in at -$0.08 , while revenue for the quarter reached $2.73M .
Earnings released on 22 Sept 2021
EPS came in at -$0.04 falling short of the estimated -$0.03 by -33.33%, while revenue for the quarter reached $4.53M .
Earnings released on 29 Jun 2021
EPS came in at -$0.02 , while revenue for the quarter reached $2.15M .
Earnings released on 24 Feb 2021
EPS came in at -$0.02 , while revenue for the quarter reached $1.45M .
Earnings released on 31 Oct 2020
EPS came in at -$0.01 , while revenue for the quarter reached $1.67M .
Earnings released on 29 Sept 2020
EPS came in at -$0.02 , while revenue for the quarter reached $1.11M .
VPHIF Stock Performance
Access detailed VPHIF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.